| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |